Paul Davies MP: speeches

Speeches

• 15 Jun 2026 · Brain Cancer · Hansard source

  More

  The simple answer is yes, I totally agree. The hon. Lady has summed it up perfectly. In 2023-24, charities provided 74% of all investment, which of course left just 26% coming from Government. There is a clear link between funding and survival. Investment enables more clinical trials, better patient recruitment and improved access to innovation. I therefore call on the Government to set out how much funding will be ringfenced, and to raise their contribution to between £45 million and £50 million by 2029 in line with the recommendations from Brain Tumour Research. At the same time, we must recognise that funding alone will not deliver the progress we urgently need. The wider research and innovation environment must be reformed so that discoveries progress more efficiently into clinical development and patient access. Discovery research is essential, yet many innovations still fail to cross the translational valley of death, where fragmented, high-risk and unsupported pathways cause breakthroughs to stall. Stronger collaboration between institutions is needed to accelerate early-stage research, and the Government should also clarify the role of UK Research and Innovation within the national cancer plan, given its central contribution to discovery science. In addition, health technology assessment reform is required so that appraisal bodies adopt fairer and more flexible cost-effectiveness thresholds for rare and less survivable cancers, including brain tumours. Patient awareness is essential. As Professor Kathreena Kurian highlighted, many patients are left unaware that they must give consent for their tumour tissue to be used in advanced diagnostics and research. Every eligible patient must have proactive conversations with their clinical team about research opportunities. Greater participation is essential to attract investment, and when trials are easier to set up and recruit for, commercial and academic partners are more likely to set up further studies in the UK. Alongside that, we must address an issue repeatedly raised by patients and families: the right to pursue innovative treatment when standard options have been exhausted. Too many families find themselves travelling abroad, seeking repurposed drugs or raising money online to access treatments. No family should be forced to remortgage their home, empty savings or appeal to strangers online simply to pursue the possibility of more time. These improvements depend on one further requirement: strong national leadership. Currently, no single body within the Government, NHS England or the wider health system holds clear ownership of brain cancer outcomes. Where responsibility is spread everywhere, accountability exists nowhere. Patients deserve to know who is responsible for delivering change. Before I close, I will return to the reason the petition exists. In October 2022, Sarah Bainbridge’s daughter Jess was diagnosed with glioblastoma, an aggressive brain cancer that, until then, her family had never heard of. Jess underwent treatment, including two operations, but her family soon realised that once the standard options were exhausted, very few alternatives remained. Like many other families, they found themselves searching beyond established pathways. Jess died in November 2023. She was just 35 years old, and had three children: Alfred, who was five, and one-year-old twins Billy and Alba. In Sarah’s words: “If I am honest, we have needed Jess every single day since she died, and we still do.” This is not just Jess’s story; it is the story of thousands of families across the UK. Following Jess’s death, Sarah met Georgie Maynard, a young mother living with glioblastoma. Although their circumstances were different, they shared the same frustration: that patients and families were still facing many of the same barriers identified decades earlier. Together, they founded Brain Cancer Justice, not for sympathy or recognition, but to call for urgent change. It was my privilege to meet with Brain Cancer Justice in the lead-up to this debate, and I encourage Ministers to do the same. This should not only be about recognition or reassurance but about ending broken promises, raising ambition and protecting delivery. Patients and families have waited long enough: we must turn “terminal” into “treatable”.

• 14 May 2026 · Business of the House · Hansard source

  More

  Recently, I was contacted by a leading manufacturer based in my constituency, Trojan Plastics, which highlighted the findings of the Made in Group’s industrial strategy survey report 2026. It found that one in four manufacturers described their energy costs over the past 12 months as “survival threatening”. While I congratulate the Government on their excellent work on delivering clean power, may we have a statement on their plans to improve energy costs for businesses?

• 19 Mar 2026 · Topical Questions · Hansard source

  More

  T6. The recent real-life drama “Dirty Business” highlighted the scale of the issues within the water industry. In my constituency, Yorkshire Water has had serious issues with sewage outflows and poor standards of infrastructure. I welcome the Government’s water reforms, which will protect customers. However, does the Secretary of State agree that we now need to consider public ownership of the water industry in order to resolve the fundamental problems it faces?

• 5 Jan 2026 · Rural Crime · Hansard source

  More

  The most common and impactful rural crimes in West Yorkshire include the theft of farm machinery, fuel and livestock, incidents of livestock worrying, and wildlife and environmental offences. Increased funding for specialist units, such as the national rural crime and the national wildlife crime units, is welcome. They will help to co-ordinate and support police forces across England and Wales to target rural crime. What other actions can the Government take to help tackle such crime?

• 17 Nov 2025 · Parkinson’s Disease · Hansard source

  More

  Again, I absolutely agree. I know from talking to one of my constituents, Liz Ryan, that that physical support and that ability to do something, get involved in activities and have help are of immense value. We absolutely have to have a holistic view of this issue; it is not a simple case of just medication or taking people into a clinical environment. We have to look at what we can do within communities, as was mentioned earlier, and at how we can support people with their lives and ensure that they live their lives to their full potential. Some of the innovative medicines can certainly be life-changing for those with severe symptoms, but staffing and funding constraints mean that many hospitals cannot offer those solutions. Access to new treatments must not be a postcode lottery. I want to take a moment to share some encouraging news from my constituency. We currently have a neurology registrar based in Leeds who is spending a significant amount of time seeing Parkinson’s patients in Huddersfield. He works alongside a dedicated doctor who also travels from Leeds to support patients at Huddersfield Royal infirmary. Just last month, they met the operations director at Huddersfield Royal infirmary, who shared some good news: in December, the trust will be advertising for a consultant neurologist with a special interest in Parkinson’s. The role will be based in Leeds but will include a significant commitment to patients in Huddersfield. That is a direct result of our local campaign, and in particular the tireless work of our local Parkinson’s community group, led by Liz Ryan MBE and Dr Chris Ryan. It shows what can be achieved when patients, families, clinicians and elected representatives work together.

• 28 Oct 2025 · Gaza: Humanitarian Situation · Hansard source

  More

  I fully support the Minister in welcoming the US-brokered ceasefire, which has enabled the delivery of much-needed humanitarian aid into Gaza. As the Minister is aware, the UN and its partners have significantly scaled up their operations providing essential supplies, such as food, water, medical aid and fuel. However, given that border closures and ongoing political tensions continue to obstruct the flow of assistance, what steps are the Government taking to ensure unimpeded humanitarian access, and to prevent aid being used as a tool of political leverage?